Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Netanyahu leads meeting on West Bank riots, Katz defends axing administrative detention for Jews - 2AfD in Brandenburg takes back suit against the intelligence service
- 3More than 3 million eye drops have been recalled from CVS, Walgreens and other national retailers. How to check if yours are safe
- 4Instructions to Investigate Different Open Record Extra Offers Actually
- 5Merz visit highlights new strategic, and strained, Germany-Israel bond
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
- This Week In Space podcast: Episode 186 — Snow on the Moon?
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- Vote in favor of your #1 Kind of Cap
- Improving as a Cook: Culinary Experiences in the Kitchen
- The Best Computer games for Multiplayer Fun
